Cellebrite DI (CLBT) Stock Analysis

Cellebrite DI (CLBT) is a publicly traded company in the TECHNOLOGY sector. It trades at $14.98, carries a market capitalization of $3.80B, a price-to-earnings ratio of 54.43. This page summarizes the public market data, fundamentals, and frequently asked questions for CLBT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: TECHNOLOGY - SOFTWARE - INFRASTRUCTURE

Exchange: NASDAQ

Key Metrics

• Price: $14.98
• Market Cap: $3.80B
• P/E Ratio: 54.43
• EPS: $0.28
• 52-Week High: $19.98
• 52-Week Low: $11.02

Market Sentiment

Cellebrite DI currently has a Bullish sentiment score of 0.31.

About Cellebrite DI

Cellebrite DI Ltd. is a premier provider of digital intelligence solutions, delivering sophisticated investigative tools and services tailored for law enforcement, military, and corporate sectors globally. Based in Petah Tikva, Israel, the company excels in digital forensics, enabling users to securely and efficiently extract, analyze, and manage data from various digital devices. Avec a strong emphasis on innovation and a commitment to user privacy and data protection, Cellebrite integrates ...

GNG Research Analysis

GNG Research scores Cellebrite DI (CLBT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CLBT.

Frequently Asked Questions

Does CLBT pay dividends?

Cellebrite DI (CLBT) does not currently pay a regular dividend.

What is CLBT's P/E ratio?

Cellebrite DI has a price-to-earnings (P/E) ratio of 54.43.

What is CLBT's market cap?

Cellebrite DI (CLBT) has a market capitalization of $3.80B with a current stock price of $14.98.